Peiwen Zhang

Peiwen Zhang

Auto-generated profile, based on publicly available information

Peiwen Zhang

Department of Nutrition School of Public Health Guangdong Medical University Zhanjiang 524023 China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
XLXiaozhuan Lin
Xiaozhuan Lin
XZXuan Zhu
Xuan Zhu
YXYan Xin
Yan Xin
PZPeiwen Zhang
Peiwen Zhang
YXYunjun Xiao
Yunjun Xiao
HGHonghui Guo
Honghui Guo

1 May 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JNJifan Nie
Jifan Nie
XMXingyuan Ma
Xingyuan Ma
FHFabiao Hu
Fabiao Hu
HMHui Miao
Hui Miao
XFXin Feng
Xin Feng
WZWenyun Zheng
Wenyun Zheng
Tumor necrosis factor (TNF-α) is an important clinically tested cytokine that could induce autoimmune diseases and inflammation. Therefore, the anti-TNF-α therapy strategy was developed and used therapeutically in various diseases, especially in the cytokine storm associated chimeric antigen receptor (CAR) T-cell therapy and antiviral therapy. Compare with other anti-TNF-α inhibitors, anti-TNF-α Nb (nanobody) has many unique advantages. Herein, we reported a novel humanized scaffold for library construction, which could be soluble and expressed in Escherichia coli (E.coli), and the efficiency capacity could reach as high as 2.01 × 109. Meanwhile, an anti-TNF-α Nb was selected for further study after 4 rounds of screening, NT-3, as the optimal Nb could effectively inhibit TNF-mediated cytotoxicity. The IC50 of NT-3 was determined as 0.804 μM, and its apoptosis inhibition rate was 62.47 % in L929 cells. Furthermore, the molecular docking results showed that complementarity-determining regions (CDRs) of NT-3 could connect to TNF for blocking function through strong hydrogen bonds and salt bridges. In general, our study not only provided a good Nb screening platform in vitro without animal immunization, but also generated a series of novel humanized anti-TNF-α Nb candidates with potential applications.